Your browser doesn't support javascript.
loading
Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma.
Ailawadhi, Sikander; DerSarkissian, Maral; Duh, Mei Sheng; Lafeuille, Marie-Hélène; Posner, George; Ralston, Stephen; Zagadailov, Erin; Ba-Mancini, Abbie; Rifkin, Robert.
Afiliação
  • Ailawadhi S; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Florida, Jacksonville, FL, USA. Electronic address: ailawadhi.sikander@mayo.edu.
  • DerSarkissian M; Groupe d'analyse, Ltée/Analysis Group, Inc, Montréal, Québec, Canada.
  • Duh MS; Groupe d'analyse, Ltée/Analysis Group, Inc, Montréal, Québec, Canada.
  • Lafeuille MH; Groupe d'analyse, Ltée/Analysis Group, Inc, Montréal, Québec, Canada.
  • Posner G; Groupe d'analyse, Ltée/Analysis Group, Inc, Montréal, Québec, Canada.
  • Ralston S; Sirius Market Access, London, United Kingdom.
  • Zagadailov E; Millennium Pharmaceuticals Inc, a Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Ba-Mancini A; Millennium Pharmaceuticals Inc, a Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Rifkin R; US Oncology Research/Rocky Mountain Cancer Centers, Denver, CO, USA.
Clin Ther ; 41(3): 477-493.e7, 2019 03.
Article em En | MEDLINE | ID: mdl-30773308

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Ther Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Ther Ano de publicação: 2019 Tipo de documento: Article